ASDG ACT/TAS State Meeting

The ACT and Tasmania are proud to be coming together to present the next ASDG state webinar. We have 3 fantastic speakers, with subjects ranging from case studies to quality improvements. These young scientists will be showcasing the fantastic work they are doing in their areas, and the important contribution they are making to quality patient care. Please join us in supporting them by joining our webinar.



Speaker 1: Amber Condell [they/them], Clinical Bioinformatician, Canberra Clinical Genomics (CCG)

Title: ‘A case of ADA2 variant homozygosity: how whole exome sequencing can consolidate clinical constellations and bring closure to arduous diagnostic odysseys’

Bio: Mx. Amber Condell is a Clinical Bioinformatician working at Canberra Clinical Genomics, and a proud disability-advocate in the Ehlers-Danlos syndrome community. They are currently in their final semester of the Master of Diagnostic Genomics programme at QUT. They have a Bachelor of Genetics from the ANU with Honours from MCRI in Melbourne. As an enthusiastic "DNA detective", they love to search the deep depths of the genome to find genetic variants which could contribute to clinical conditions, hopefully assisting in bringing genomic closure for patients on their diagnostic journeys where possible.


Speaker 2: Laura King-Grey, Cytogenetics and Molecular Medicine, Royal Hobart Hospital Pathology

Title: 'CD138 Enrichment Method Review'

Bio: Laura King-Grey is a Medical Scientist who graduated from the University of Tasmania with a Bachelor of Biomedical Science in 2019. She began working in her current role at the Cytogenetics Department of the Royal Hobart Hospital shortly afterwards. She has emersed herself into workplace-based training in a discipline not specifically covered by her studies, and as an avid puzzle-solver has particularly enjoyed performing karyotyping and FISH analysis in the field of acquired cytogenetics. She has long had a passion for genetics and is excited to pursue future opportunities in this space.


Speaker 3: Sally Rowlinson, Diagnostic Genomics, ACT Pathology, Canberra Hospital

Title: ‘The use of SNP Microarray as a diagnostic and monitoring tool for common specific chromosomal abnormalities in Chronic Lymphocytic Leukaemia’

Bio: Ms. Sally Anne Rowlinson is a Scientist at ACT Pathology within the Diagnostic Genomics division. She is currently in her final year of Master of Medical Sciences via Dissertation at CSU. She has previously completed a Bachelor of Science(Biotechnology) from RMIT and short course in Bioethics from Harvard Online. She hopes that the findings of this project can go towards improving diagnosis accuracy and provide increased availability to personalized treatment and potentially reduce the cost and diagnosis times to those in the Canberra region and surrounds that have been diagnosed with Chronic Lymphocytic Leukaemia.





29/03/2023 1:00 PM - 2:00 PM
AUS Eastern Daylight Time